Verger, Emmanuelle
Soret-Dulphy, Juliette
Maslah, Nabih
Roy, Lydia
Rey, Jerome
Ghrieb, Zineb
Kralovics, Robert
Gisslinger, Heinz
Grohmann-Izay, Barbara
Klade, Christoph
Chomienne, Christine
Giraudier, Stéphane
Cassinat, Bruno
Kiladjian, Jean-Jacques
Funding for this research was provided by:
Institut National Du Cancer (2014-1-PL BIO-12, “CTIM3, 2014-1-PL BIO-12, “CTIM3)
Article History
Received: 14 August 2018
Revised: 24 August 2018
Accepted: 5 September 2018
First Online: 4 October 2018
Conflict of interest
: Dr Cassinat and Dr Kiladjian received institutional research grants from Novartis and AOP Orphan; Dr Kiladjian participated in advisory boards for Novartis and AOP Orphan.
: The study was approved by the local ethics committee (IRB0006477). All patients participating in the PROUD-PV clinical trial (NCT01949805) provided informed consent.